TY  - GEN
AU  - Hasvold,L P
AU  - Bodegård,J
AU  - Thuresson,M
AU  - Stålhammar,J
AU  - Hammar,N
AU  - Sundström,J
AU  - Russell,D
AU  - Kjeldsen,S E
TI  - Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients
SN  - 1476-5527
PY  - 2015///0615
KW  - Aged
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - therapeutic use
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Benzimidazoles
KW  - Biphenyl Compounds
KW  - Blood Pressure
KW  - drug effects
KW  - Cardiovascular Diseases
KW  - diagnosis
KW  - Diabetes Mellitus, Type 2
KW  - Enalapril
KW  - Female
KW  - Humans
KW  - Hypertension
KW  - Incidence
KW  - Male
KW  - Middle Aged
KW  - Primary Health Care
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Sweden
KW  - epidemiology
KW  - Tetrazoles
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/jhh.2014.43
ER  -